The last year has seen several waves of federal policy updates affecting healthcare as President Donald Trump and his administration took on the first year of his second term in office. Here are eight ...

Atea Pharmaceuticals (AVIR) offers a late-stage, best-in-class HCV cure, with significant upside, currently trading below cash. BEM/RZR combines advantages of current first-line HCV therapies — single ...

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...

Dec 19 (Reuters) - U.S. President Donald Trump ‌and ​nine major pharmaceutical companies on Friday announced ‌deals that will slash the prices of their medicines for the government's Medicaid program ...

Ultimately, AI enables loyalty programs to operate at a micro, highly personalized level, using historical data to drive ...

Author Steven C. Smith talks about his absorbing new book, 'Hitchcock and Herrmann: The Friendship and Film Scores that ...

Health Canada's Pharmaceutical Drugs Directorate (PDD) and the U.S. Food and Drug Administration's (FDA) Office of Generic Drugs (OGD) have created a program to support the establishment of a Request ...

On October 3, 2025, the U.S. Food and Drug Administration (FDA) announced a prioritization pilot program for reviewing abbreviated new drug applications (ANDAs). ANDAs are submissions for generic ...

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

Rollercoaster Tycoon wasn’t the most fashionable computer game out there in 1999. But if you took a look beneath the pixels—the rickety rides, the crowds of hungry, thirsty, barfing people (and the ...

According to Nova One Advisor, the U.S. generic drugs market size is expected to be worth around 196.90 billion by 2034, increasing from USD 138.24 billion in 2024, representing a healthy CAGR of 3.6% ...